Oral administration of type-II collagen peptide 250–270 suppresses specific cellular and humoral immune response in collagen-induced arthritis

2007 ◽  
Vol 122 (1) ◽  
pp. 75-84 ◽  
Author(s):  
Ping Zhu ◽  
Xiao-Yan Li ◽  
Hong-Kun Wang ◽  
Jun-Feng Jia ◽  
Zhao-Hui Zheng ◽  
...  
1987 ◽  
Vol 42 (3) ◽  
pp. 311-318
Author(s):  
Nobuhiro Kaibara ◽  
Kenji Takagishi ◽  
Takao Hotokebuchi ◽  
Masahiro Morinaga ◽  
Chikafumi Arita ◽  
...  

2005 ◽  
Vol 35 (5) ◽  
pp. 1643-1652 ◽  
Author(s):  
Harald Burkhardt ◽  
Bettina Sehnert ◽  
Robert Bockermann ◽  
Åke Engström ◽  
Jochen R. Kalden ◽  
...  

2005 ◽  
Vol 33 (04) ◽  
pp. 651-661 ◽  
Author(s):  
Chian-Jiun Liou ◽  
Wen-Chung Huang ◽  
Jerming Tseng

Ginseng radix (Panax ginseng C.A. Meyer) is a popular herbal medicine in Oriental countries. We investigated the effect of long-term oral administration of ginseng extract on the antigen-specific antibody response. Male BALB/c mice were treated orally for 30 consecutive days with 2 g/kg of a 50% ethanol extract of ginseng root. Mice treated with ginseng and immunized with ovalbumin (OVA), resulting in an eight-fold increase in titers of anti-OVA immunoglobulin (Ig)G in the serum compared to the group receiving OVA immunization without ginseng treatment; the level of IgG was also significantly elevated in the mice treated with ginseng and immunized with OVA. Mice treated with ginseng without OVA immunization exhibited significantly reduced IgG and IgA production by spleen cells. However, IgG production was not affected in mice treated with ginseng and OVA immunization in spleen cells. Interleukin (IL)-2, interferon (IFN)-γ and IL-4 secretion by spleen cells from either ginseng-treated mice or OVA-immunized mice were down-regulated compared to that in the control group; while the production of IL-10 was unchanged. The percentage of CD8+ cells was significantly reduced in spleen cells from ginseng-treated, OVA-immunized mice. Thus, long-term oral administration of ginseng extract appears to potentiate humoral immune response but suppress spleen cell functions.


1989 ◽  
Vol 76 (5) ◽  
pp. 535-538 ◽  
Author(s):  
L. M. Killar ◽  
C. J. Dunn

1. The subcutaneous administration of recombinant human interleukin-1β (rhIL-1β) was found to induce an increased incidence and earlier onset of collagen-induced arthritis in mice. 2. The rhIL-1β had different effects, depending on when it was administered after collagen-immunization. 3. The effect of rhIL-1β may be due, in part, to augmentation of the immune response to type II collagen. 4. Interleukin-1-accelerated, collagen-induced arthritis will provide a useful model for investigating the role of interleukin-1 in the regulation of arthritic diseases, and the development of anti-arthritic therapeutics.


Sign in / Sign up

Export Citation Format

Share Document